![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
BV Clineschmidt, DR Reiss, DJ Pettibone and JL Robinson
1-Arylpiperazines (MK-212, quipazine, m-chlorophenylpiperazine and m- trifluoromethylphenylpiperazine) caused a serotonin (5-HT) receptor- mediated contraction of rat fundic strips. m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazine had high affinity for the receptor but little efficacy, whereas quipazine and MK-212 had lesser affinity and much greater efficacy. 5-HT itself was the most potent (EC50 = 6-9 nM) agonist and possessed the greatest affinity (KA = 9.7 nM). Assessment of receptor occupancy vs. functional response (as well as receptor alkylation studies) demonstrated a very small, if any, receptor reserve in this tissue. Several arylquinolizines were found to be competitive antagonists of 5-HT-induced contraction, the most potent being L-653,267 and rauwolscine (KB values = 1.9 and 3.8 nM). Clozapine, trazodone and propranolol were identified as less potent, competitive antagonists, whereas various ergolines (including LY 53857), L-646,462 (cyproheptadine analog) and mianserin were noncompetitive. Potent 5-HT2 receptor antagonists (pirenpirone and ketanserin) antagonized only weakly or were without effect against 5- HT, indicating that the fundic 5-HT receptor is not of the 5-HT2 subtype. Because the fundic receptor has high affinity for 5-HT (as does the 5-HT1 binding site in brain tissue), the possible correspondence of the fundic 5-HT receptor with the 5-HT1 recognition site in rat brain cortex was considered. 5-HT, the nonindole agonists (1-arylpiperazines) and the competitive antagonists all competed with [3H]-5-HT for the 5-HT1 site. However, all compounds except 5-HT had Hill slopes significantly less than 1.0, precluding a valid comparison with dissociation constants derived pharmacologically in the fundus. With respect to having a high affinity for 5-HT, the 5-HT receptor mediating contraction of fundic smooth muscle resembles the 5-HT1 recognition site (as defined in brain tissue by radioligand binding), but identity remains unproven.
This article has been cited by other articles:
|
|
 |
|
  L. Xue, M. Camilleri, G. R. Locke III, J. A. J. Schuurkes, A. Meulemans, B. J. Coulie, J. H. Szurszewski, and G. Farrugia Serotonergic modulation of murine fundic tone Am J Physiol Gastrointest Liver Physiol, December 1, 2006; 291(6): G1180 - G1186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Marcoli, G. Maura, M. Tortarolo, and M. Raiteri Trazodone is a Potent Agonist at 5-HT2C Receptors Mediating Inhibition of the N-Methyl-D-Aspartate/Nitric Oxide/Cyclic GMP Pathway in Rat Cerebellum J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 983 - 986. [Abstract] [Full Text]
|
|
|
|
|
|
E. Fiorica-Howells, R. Hen, J. Gingrich, Z. Li, and M. D. Gershon 5-HT2A receptors: location and functional analysis in intestines of wild-type and 5-HT2A knockout mice Am J Physiol Gastrointest Liver Physiol, May 1, 2002; 282(5): G877 - G893. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
